REFERENCES
- Andersson, L., Edsmyr, F., Jönsson, G. & Könyves, I. 1977. Estramustine phosphate therapy in carcinoma of the prostate. Recent Results in Cancer Research 60, 73.
- Andersson, S.-B., Gunnarsson, P. O., Nilsson, T. & Plym Forshell, G. 1981. Metabolism of estramustine phosphate (ESTRACYT®) in patients with prostatic carcinoma. Eur J Drug Metab Pharmacokin 6, 149.
- Andersson, S.-B., Lundgren, R. & Svensson, L. 1981. Gas chromatographic determination of the metabolites of estramustine phosphate in plasma. Acta Pharm Suec. In press.
- Brenner, P. F., Guerrero, R., Cekan, S. Z. & Diczfalusy, E. 1973. Radioimmunoassay method for six steroids in human plasma. Steroids 22, 775.
- Dixon, R., Brooks, M. & Gill, G. 1980. Estramustine phosphate: Plasma concentrations of its metabolites following oral administration to man, rat and dog. J Chromatogr 27, 17.
- Forsgren, B., Gunnarsson, P. O., Johanssonn, S.-Å. & Kant, R. 1978. Radioimmunoassay of estramustine phosphate in plasma. Acta Pharm Suec 15, 200.
- Forsgren, B., Gustafsson, J.-Å., Pousette, Å. & Högberg, B. 1979. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of estradiol-17β. Cancer Res 39, 5155.
- Fritjofsson, Å., Norlén, B. J., Högberg, B., Rajalakshmi, M., Cekan, S. Z. & Diczfalusy, E. 1981. Hormonal effects of different doses of estramustine phosphate (Estracyt®) in patients with prostatic carcinoma. Scand J Urol Nephrol 15, 37.
- von Hoff, D. D., Rozencweig, M., Slavik, M. & Muggia, F. M. 1977. Estramustine phosphate: A specific chemotherapeutic agent? J Urol 117, 464.
- Högberg, B., Björk, P., Karlström, R., Forsgren, B., Gustafsson, J.-Å., Hökfelt, T. & Pousette, Å. 1979. The interaction of steroidal alkylating agents with binding components in the soluble fraction of the prostate. In: Prostate cancer and hormone receptors. Alan Liss Inc., New York, pp. 181–199.
- Jönsson, G., Högberg, B. & Nilsson, T. 1977. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt®). Scand J Urol Nephrol 11, 231.
- Kadohama, N., Kirdani, R. Y., Madajewicz, S., Murphy, G. P. & Sandberg, A. A. 1979. Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer. N Y State J Med 79, 1105.
- Kadohama, N., Kirdani, R. Y., Murphy, G. P. & Sandberg, A. A. 1978. Estramustine phosphate: Metabolic aspects related to its action in prostatic cancer. J Urol 119, 235.
- Kirdani, R. Y., Mittelman, A., Murphy, G. P. & Sandberg, A. A. 1975. Studies of phenolic steroids in human subjects. XIV. Fate of a nitrogen mustard of Estradiol-17β. J Clin Endocrinol Metab 41, 305.
- Mittelman, A., Shukla, S. K. & Murphy, G. P. 1976. Extended therapy of stage D carcinoma of the prostate with oral Estracyt. J Urol 115, 409.
- Nagel, R. & Kölln, C.-P. 1977. Treatment of advanced carcinoma of the prostate with Estracyt. Br J Urol 49, 73.
- Plym Forshell, G., Müntzing, J., Ek, A., Lindstedt, E. & Dencker, H. 1976. The absorption, metabolism and excretion of Estracyt in patients with prostatic cancer. Invest Urol 14, 128.